US health authorities have given their approval to dengue vaccine Dengvaxia, the controversial first treatment designed to protect against the deadly mosquito-borne virus. The Food and Drug Administration made the announcement on Wednesday, but the use of the vaccine can only occur under certain strict conditions: only children aged between nine and 16, who have previously confirmed infections, and who live in endemic areas, may receive the dose. “While there is no cure for dengue disease… approval is an important step toward helping to reduce the impact of this virus,” said Anna Abram, a senior FDA official. The virus is endemic in the US territories of American Samoa, Guam, Puerto Rico and the US Virgin Islands, said the FDA. Dengue, which causes hemorrhagic fever, is the world’s most common mosquito-borne virus and infects an estimated 390 million people in more than 120 countries each year — killing more than 25,000 of them, according to the World Health Organization. But Dengvaxia, produced by the French pharmaceutical firm Sanofi Pasteur, is controversial: the Philippines, which became the first country to approve it in 2016, was also the first to ban it in February this year over safety concerns. Manila is also pursuing… Read full this story
- Taiwan approves Gilead's remdesivir to treat COVID-19
- First signs if a COVID-19 vaccine works possible in autumn: GAVI
- Coronavirus: 99% chance that COVID-19 vaccine will work, says Chinese firm
- Coronavirus vaccine ‘99% likely to work and can be given to 100 million people’, Chinese firm claims
- Coronavirus: Why do healthy people volunteer to be vaccine guinea pigs?
- Chinese Scientist ’99%' Sure That COVID-19 Vaccine Will Prove Successful - Report
- LA's Poor Should Get Priority For Coronavirus Vaccine: Councilman
- Coronavirus live updates: Masks could be required until vaccine arrives, San Francisco official says
- Taiwan approves Gilead’s remdesivir to treat Covid-19
- EPL teams approve contact training as players’ fears linger
US approves dengue vaccine Dengvaxia have 311 words, post on en.rfi.fr at May 2, 2019. This is cached page on Asean Breaking News. If you want remove this page, please contact us.